Multimodal platform for assessing drug distribution and response in clinical trials
Begoña Giménez(Brigham and Women's Hospital), Nathalie Y.R. Agar(Texas Endosurgery Institute), Sandro Santagata(Harvard University), Keith L. Ligon(Brigham and Women's Hospital), Stuart A. Grossman(Johns Hopkins University), Elizabeth C. Randall(Brigham and Women's Hospital), Jann N. Sarkaria(Mayo Clinic in Arizona), Patrick Y. Wen(Dana-Farber Cancer Institute), Eudocia Q. Lee(Brigham and Women's Hospital), Danielle M. Burgenske(Mayo Clinic in Arizona), Ishwar N. Kohale(Amgen (United States)), Brian M. Alexander(Brigham and Women's Hospital), Ilya Korsunsky(Broad Institute), Sankha S. Basu(Brigham and Women's Hospital), Jeffrey N. Agar(Northeastern University), Sylwia A. Stopka(Brigham and Women's Hospital), Amanda R. Clark(Brigham and Women's Hospital), Ziming Du(Fuyang City People's Hospital), Michael S. Regan(Brigham and Women's Hospital), Yang Dai(Brigham and Women's Hospital), Burt Nabors(University of Alabama at Birmingham), Walid M. Abdelmoula(Brigham and Women's Hospital), Soumya Raychaudhuri(Broad Institute), Bianca M. Marin(Mayo Clinic), Jeffrey G. Supko(Harvard University), Giorgio Gaglia(Boston University), Ann C. Mladek(Mayo Clinic), Forest M. White(Center for Cancer Research)
Cited by 14
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k